
The treatment of zzso diseases has become increasingly dependent on tumor biology and is focused on targeted zzso zzso complex networks of zzso signaling zzso zzso of specific targets and a myriad of other approaches has brought new fuel to the battle against many types of zzso Unfortunately, the degree of benefit achieved in this new era of cancer treatment has not been distributed zzso among the different disease zzso zzso with lower zzso rates, but that are also highly challenging, are not consistently given due attention by research zzso This article aims to evaluate new insights and potential gains obtained with new therapies in a particular group of zzso those rarely debated in clinical practice, but which still pose a considerable challenge to clinical zzso 

